- Joined
- Dec 25, 2007
- Messages
- 157
- Reaction score
- 0
I was reading through the guidelines/recommendations as well as the study this was based upon.
What's not making sense to me is that it is stated that in medical patients, using heparin or similar agents have no statistically significant reduction in the risk for mortality or symptomatic DVT. However, PE was significantly reduced
Is this not contradictory?
Also, in their recommendation it is stated to use heparin after weighing the risks and benefits...
Why should we use DVT prophylaxis if there is no significant decrease in mortality. Also, are there in formal tools to evalute risk and benefits or am I just using well's criteria, DVT risk factors?
Thanks to anyone who can clear this up for me!
What's not making sense to me is that it is stated that in medical patients, using heparin or similar agents have no statistically significant reduction in the risk for mortality or symptomatic DVT. However, PE was significantly reduced
Is this not contradictory?
Also, in their recommendation it is stated to use heparin after weighing the risks and benefits...
Why should we use DVT prophylaxis if there is no significant decrease in mortality. Also, are there in formal tools to evalute risk and benefits or am I just using well's criteria, DVT risk factors?
Thanks to anyone who can clear this up for me!